The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ultragenyx Pharmaceutical Inc. since 2020.
This trader's CIK number is 1515673.
At the time of last reporting, Ultragenyx Pharmaceutical Inc. was the Director of Arcturus Therapeutics Holdings Inc.. (stock ticker symbol ARCT).
Also see all insider trading activities at Arcturus Therapeutics Holdings Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ARCT | 0 | $0 | 800,000 | $43,631,250 | 0 | $0 |
| 2020 | ARCT | 0 | $0 | 800,000 | $80,650,634 | 600,000 | $9,600,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-11 | ARCT | Sale | 75,000 | 45.83 | 3,437,250 |
| 2021-08-10 | ARCT | Sale | 725,000 | 55.44 | 40,194,000 |
| 2020-12-09 | ARCT | Sale | 357,745 | 94.97 | 33,975,042 |
| 2020-12-08 | ARCT | Sale | 442,255 | 105.54 | 46,675,592 |
| 2020-05-20 | ARCT | Option Ex | 600,000 | 16.00 | 9,600,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ultragenyx Pharmaceutical Inc. (Director of Arcturus Therapeutics Holdings Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.